Figure 6.
P53 loss fully rescues HSPC survival and hematopoiesis defects caused by CHD8 deletion. (A) Efficient deletion of CHD8 or P53 shown by western blot analysis in Chd8−/−, P53−/−, and Chd8−/−P53−/− BM progenitors. (B) Total cellularity of BM cells in WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− mice after 6 days of pI/pC injections. *P < .05; ***P < .001. WT represents Chd8F/FP53F/F mice. (C) Flow cytometry of LSK and LK cells in WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− BM. Representative dot plots and frequencies of the HSPC subpopulations in lineage− cells are shown. (D) Absolute number of LSK and LK cells from WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− mice after 6 days of pI/pC injections. **P < .01; ***P < .001. (E) Percentage of apoptotic (annexin V+; 4′,6-diamidino-2-phenylindole−) SLAM HSCs and LKs in WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− mice. ***P < .001; **P < .01; *P < .05. (F) Percentage of CD45.2 cells at different time points in the PB after pI/pC injection in successfully reconstituted mice. (G) Percentage of CD45.2 BM progenitors in the transplant-recipient mice after 4 months of pI/pC injections. *P < .05; **P < .01; ns, not significant. (H) Heat map of all differentially expressed transcripts in WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− LSK RNA sequencing.

P53 loss fully rescues HSPC survival and hematopoiesis defects caused by CHD8 deletion. (A) Efficient deletion of CHD8 or P53 shown by western blot analysis in Chd8−/−, P53−/−, and Chd8−/−P53−/− BM progenitors. (B) Total cellularity of BM cells in WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− mice after 6 days of pI/pC injections. *P < .05; ***P < .001. WT represents Chd8F/FP53F/F mice. (C) Flow cytometry of LSK and LK cells in WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− BM. Representative dot plots and frequencies of the HSPC subpopulations in lineage cells are shown. (D) Absolute number of LSK and LK cells from WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− mice after 6 days of pI/pC injections. **P < .01; ***P < .001. (E) Percentage of apoptotic (annexin V+; 4′,6-diamidino-2-phenylindole) SLAM HSCs and LKs in WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− mice. ***P < .001; **P < .01; *P < .05. (F) Percentage of CD45.2 cells at different time points in the PB after pI/pC injection in successfully reconstituted mice. (G) Percentage of CD45.2 BM progenitors in the transplant-recipient mice after 4 months of pI/pC injections. *P < .05; **P < .01; ns, not significant. (H) Heat map of all differentially expressed transcripts in WT, Chd8−/−, P53−/−, and Chd8−/−P53−/− LSK RNA sequencing.

Close Modal

or Create an Account

Close Modal
Close Modal